Search
Patexia Research
Case number 1:18-cv-01674

Helsinn Healthcare S.A. et al v. Baxter Healthcare Corporation > Documents

Date Field Doc. No.Description (Pages)
Jul 9, 2020 1 Complaint (7)
Aug 9, 2019 21 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,598,219 B2; 8,729,094 B2. (Attachments: # (1) Order)(nms)
Aug 9, 2019 21 Order (4)
Aug 9, 2019 21 Patent/Trademark Report to Commissioner (1)
Aug 5, 2019 20 Order (4)
Docket Text: SO ORDERED Granting [19] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 8/5/2019. (nms)
Jul 22, 2019 19 Stipulation of Dismissal (4)
Docket Text: STIPULATION of Dismissal, by Baxter Healthcare Corporation. (Rovner, Philip) Modified on 7/22/2019 (nms).
Jul 9, 2019 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [18] STIPULATION TO EXTEND TIME for Baxter to answer, move or otherwise respond to the Complaint to August 5, 2019 (*Reset Answer Deadlines: Baxter Healthcare Corporation answer due 8/5/2019). Signed by Judge Richard G. Andrews on 7/9/2019. (nms)
Jul 8, 2019 18 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for Baxter to answer, move or otherwise respond to Plaintiffs' Complaint to August 5, 2019 - filed by Baxter Healthcare Corporation. (Rovner, Philip)
Jun 11, 2019 N/A SO ORDERED (0)
Jun 10, 2019 17 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Complaint to July 8, 2019 - filed by Baxter Healthcare Corporation. (Rovner, Philip) Modified on 6/11/2019 (nms).
May 13, 2019 16 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Complaint to June 10, 2019 - filed by Baxter Healthcare Corporation. (Rovner, Philip)
May 13, 2019 N/A SO ORDERED (0)
Apr 9, 2019 15 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiffs' Complaint to May 13, 2019 - filed by Baxter Healthcare Corporation. (Rovner, Philip)
Apr 9, 2019 N/A SO ORDERED (0)
Feb 21, 2019 N/A SO ORDERED (0)
Feb 20, 2019 14 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiffs' Complaint to April 11, 2019 - filed by Baxter Healthcare Corporation. (Rovner, Philip)
Dec 21, 2018 N/A SO ORDERED (0)
Dec 19, 2018 13 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiffs' Complaint to February 25, 2019 - filed by Baxter Healthcare Corporation. (Rovner, Philip)
Nov 16, 2018 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
Nov 7, 2018 N/A SO ORDERED (0)
Nov 7, 2018 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney William A. Rakoczy,Tara M. Raghavan for Baxter Healthcare Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak)
Nov 5, 2018 12 Motion for Leave to Appear Pro Hac Vice (10)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joseph M. O'Malley, Jr., Eric W. Dittmann, Young J. Park, Isaac S. Ashkenazi, Dana Weir and Maria C. Nunez of Paul Hastings LLP - filed by Helsinn Advanced Synthesis S.A., Helsinn Birex Pharmaceuticals Ltd., Helsinn Healthcare S.A., Helsinn Therapeutics (U.S.), Inc.. (Jacobs, Karen)
Oct 31, 2018 N/A Case Assigned/Reassigned (0)
Oct 29, 2018 11 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy and Tara M. Raghavan - filed by Baxter Healthcare Corporation. (Rovner, Philip)
Oct 29, 2018 10 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Elus Holdings Corp., Other Affiliate Helsinn Holding S.A., Other Affiliate Elathon International S.A., Other Affiliate Esker International S.A., Other Affiliate Elesk Ireland Ltd. for Helsinn Therapeutics (U.S.), Inc. filed by Helsinn Therapeutics (U.S.), Inc.. (Blumenfeld, Jack)
Oct 29, 2018 9 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Helsinn Holding S.A. for Helsinn Healthcare S.A. filed by Helsinn Healthcare S.A.. (Blumenfeld, Jack)
Oct 29, 2018 8 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Elesk Ireland Ltd, Corporate Parent Elathon International S.A., Other Affiliate Helsinn Holding S.A., Other Affiliate Esker International S.A. for Helsinn Birex Pharmaceuticals Ltd. filed by Helsinn Birex Pharmaceuticals Ltd.. (Blumenfeld, Jack)
Oct 29, 2018 7 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Helsinn Holding S.A. for Helsinn Advanced Synthesis S.A. filed by Helsinn Advanced Synthesis S.A.. (Blumenfeld, Jack)
Oct 26, 2018 6 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Helsinn Healthcare S.A., Helsinn Advanced Synthesis S.A., Helsinn Birex Pharmaceuticals Ltd., Helsinn Therapeutics (U.S.), Inc.: For Baxter Healthcare Corporation waiver sent on 10/26/2018, answer due 12/26/2018. (Blumenfeld, Jack)
Oct 26, 2018 5 Request for Waiver of Service (1)
Docket Text: REQUEST FOR WAIVER of Service sent to Baxter Healthcare Corporation on 10/26/2018 by Helsinn Advanced Synthesis S.A., Helsinn Birex Pharmaceuticals Ltd., Helsinn Healthcare S.A., Helsinn Therapeutics (U.S.), Inc.. (Blumenfeld, Jack)
Oct 26, 2018 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Baxter Healthcare Corporation on 10/26/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg)
Oct 25, 2018 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,598,219 B2; 8,729,094 B2. (ceg)
Oct 25, 2018 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/12/2018. Date of Expiration of Patent: 1/30/2024.Thirty Month Stay Deadline: 3/12/2021. (ceg)
Oct 25, 2018 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg)
Oct 25, 2018 1 Civil Cover Sheet (1)
Oct 25, 2018 1 Main Document (7)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Baxter Healthcare Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2489715.) - filed by Helsinn Healthcare S.A., Helsinn Advanced Synthesis S.A., Helsinn Birex Pharmaceuticals Ltd., Helsinn Therapeutics (U.S.), Inc. (Attachments: # (1) Exhibits A-B, # (2) Civil Cover Sheet)(ceg)
Oct 25, 2018 1 Exhibits A-B (26)
Oct 25, 2018 1 Complaint* (1)
Menu